This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Crescita Therapeutics, Inc.
Drug Names(s): ibuprofen
Description: IBUFOAM is a topical foam formulation of ibuprofen.
Nuvo and Crescita
In September 2015, Nuvo Research announced that it plans to split Nuvo into two separate, publicly traded companies. The Reorganization was completed in March 2016. As a result of the Reorganization, the shareholders of what was formerly Nuvo Research now own 100% of Nuvo Pharmaceuticals, a revenue and EBITDA generating commercial healthcare company, and 100% of Crescita Therapeutics, a drug development company.
Additional information available to subscribers only: